Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CPSH vs CRNT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CRNT Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)
CRNT Overall Winner
6-Pillar Tally: CPSH 0 – 6 CRNT
Matrix Metrics: CPSH 2 – 8 CRNT
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over CPS Technologies Corp. (CPSH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CPSH carries a Unified Composite Score of 26.4/100 (SELL) at $3.71 (67.7x Forward P/E, -1.6% operating margin), whereas CRNT carries 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin).
- Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CPSH (26.4/100 SELL) and CRNT (26.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
- Technical & Structure Timing Caution: CPSH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6); meanwhile CRNT is in a Breakdown options structure phase (RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About CPSH vs CRNT
CPSH
CPS Technologies Corp. Common Stock
$3.71
-8.74% 1D
Market Cap
$79.6M
TTM Revenue
$32M
Forward P/E
67.7x
Beta / 30D Vol
3.09β · 84% Vol
Unified Composite Score
26.4
SELL
Tech 50.0
Fund 35.0
Flow 53.0
Mom 54.0
Weinstein Technical Phase
Distribution · Trim / tighten stop
CRNT
Head-to-Head Winner
Ceragon Networks Ltd
$2.36
-1.26% 1D
Market Cap
$217.2M
TTM Revenue
$357M
Forward P/E
13.7x
Beta / 30D Vol
1.84β · 77% Vol
Unified Composite Score
26.6
SELL
Tech 50.0
Fund 35.0
Flow 58.0
Mom 50.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (CPSH 0 – 6 CRNT)
1. Valuation Multiples
CRNT
Forward P/E
67.7x
13.7x
Trailing P/E
70.9x
15.7x
PEG Ratio
N/M
8.80x
EV / Revenue
2.6x
0.6x
2. Growth & Scale
CRNT
Revenue Growth (YoY)
+1.1%
+11.7%
Earnings Growth (YoY)
+78.6%
N/A
TTM Revenue (USD)
$32M
$357M
Market Cap
$79.6M
$217.2M
3. Profitability & Quality
CRNT
Gross Margin
15.1%
34.1%
Operating Margin
-1.6%
3.5%
Net Profit Margin
0.3%
-0.3%
Return on Equity (ROE)
0.4%
-0.5%
4. Balance Sheet & Cash Flow
CRNT
Cash Generation (TTM)
-$4.0M
$13M
Cash Flow Margin
-12.2%
3.6%
Net Cash / Leverage
$6.1M Net Debt (0.26x D/E)
$6.0M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
CRNT
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
160.7% (62nd %ile)
43.7% (7th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Distribution
ACCUMULATION · Markup
6. R&D & Supply-Chain Moat
CRNT
OpEx & R&D Intensity
16.7% of Rev ($5.4M)
30.6% of Rev ($109M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Electronic Components Operator
Communication Equipment Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: CPSH (2) vs CRNT (8)| Institutional Metric | CPSH | CRNT | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $79.6M | $217.2M | CRNT | |
| Trailing P/E Ratio | 70.9x | 15.7x | CRNT | |
| Forward P/E Ratio | 67.7x | 13.7x | CRNT | |
| Revenue Growth (YoY) | +1.1% | +11.7% | CRNT | |
| Operating Margin (TTM) | -1.6% | 3.5% | CRNT | |
| Net Profit Margin | 0.3% | -0.3% | CPSH | |
| Return on Equity (ROE) | 0.4% | -0.5% | CPSH | |
| 52-Week Range Position | 6% ($3–$14) | 35% ($2–$3) | CRNT | |
| Beta / 30D Volatility | 3.09β · 84% Vol | 1.84β · 77% Vol | CRNT | |
| Unified Institutional Score | 26.4 / 100 (SELL) | 26.6 / 100 (SELL) | CRNT | |
| Trailing 12M Revenue (USD) | $32M | $357M | Scale | |
| Gross Profit Margin (TTM) | 15.1% | 34.1% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 2.6x EV/Rev | 8.80x PEG · 0.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$4.0M ($6.1M Net Debt (0.26x D/E)) | $13M ($6.0M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
CRNT +10.13 pp
3M Horizon
CRNT +23.85 pp
6M Horizon
CRNT +24.77 pp
1Y Horizon
CRNT +2.35 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CPSH Revenue | CRNT Revenue | CPSH Op. Margin | CRNT Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $20M | $340M | -4.2% | 7.6% | CRNT |
| FY2019 | $20M | $290M | -2.8% | 2.6% | CRNT |
| FY2020 | $20M | $260M | 4.4% | -2.9% | CPSH |
| FY2021 | $20M | $290M | 2.3% | 1.7% | CPSH |
| FY2022 | $30M | $300M | 8.4% | -3.7% | CPSH |
| FY2023 | $30M | $350M | 6.2% | 6.1% | CPSH |
| FY2024 | $20M | $390M | -20.7% | 9.8% | CRNT |
| FY2025 | $30M | $340M | 1.4% | 2.1% | CRNT |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
CPSH
BREAKDOWN
Current IV
160.7%
IV Percentile
62nd %ile
Put/Call OI Skew
N/A
IV Regime
Elevated (60th–80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact CPSH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CRNT
BREAKDOWN
Current IV
43.7%
IV Percentile
7th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact CRNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
CPSH Moat Profile
Cyclical / Execution-Driven Positioning
Electronic Components Operator
OpEx & R&D Reinvestment
16.7% of Rev ($5.4M)
90D Engineering Disclosures
0 Published
CRNT Moat Profile
Cyclical / Execution-Driven Positioning
Communication Equipment Operator
OpEx & R&D Reinvestment
30.6% of Rev ($109M)
90D Engineering Disclosures
0 Published
Investor FAQ CPSH vs CRNT Key Questions & Quantitative Answers
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over CPS Technologies Corp. (CPSH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CPSH carries a Unified Composite Score of 26.4/100 (SELL) at $3.71 (67.7x Forward P/E, -1.6% operating margin), whereas CRNT carries 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin). Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CPSH (26.4/100 SELL) and CRNT (26.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CPSH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6); meanwhile CRNT is in a Breakdown options structure phase (RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CRNT leads the Growth & Scale pillar: CPSH posts +1.1% YoY revenue growth and +78.6% YoY earnings growth on $32M TTM revenue (15.1% gross margin, -1.6% operating margin), compared with CRNT at +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CPSH cumulative revenue shifted +50.0% while CRNT shifted +0.0%. In operating R&D and SG&A reinvestment, CPSH deploys 16.7% of Rev ($5.4M) (0 90-day corporate R&D disclosures) versus 30.6% of Rev ($109M) (0 disclosures) for CRNT.
CRNT screens cheaper on headline valuation multiples. CPSH trades at 67.7x Forward P/E, 70.9x Trailing P/E, N/M PEG, and 2.6x EV/Revenue (-12.2% FCF margin), whereas CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CPSH (0.4% ROE) versus CRNT (-0.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CPSH carries 160.7% implied volatility (62nd %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.09β · 84% Vol realized risk). By comparison, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.84β · 77% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CRNT vs CPSH · Reverse Pair
CRNT vs GILT
· Sector Peer
CRNT vs SENS
· Sector Peer
CRNT vs INSG
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking